The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review
The PI3K/AKT pathway is one of the most frequently over-activated intracellular pathways in several human cancers. This pathway, acting on different downstream target proteins, contributes to the carcinogenesis, proliferation, invasion, and metastasis of tumour cells. A multi-level impairment, invol...
Main Authors: | Federica Rascio, Federica Spadaccino, Maria Teresa Rocchetti, Giuseppe Castellano, Giovanni Stallone, Giuseppe Stefano Netti, Elena Ranieri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3949 |
Similar Items
-
Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
by: Hai-Long LI, et al.
Published: (2022-07-01) -
Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs
by: Wan Linyan, et al.
Published: (2022-10-01) -
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
by: Wojciech Wiese, et al.
Published: (2023-11-01) -
Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
by: Fei Xu, et al.
Published: (2020-04-01) -
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
by: Charles N. Landen, et al.
Published: (2013-04-01)